Cargando…

Novel Anti-FOLR1 Antibody–Drug Conjugate MORAb-202 in Breast Cancer and Non-Small Cell Lung Cancer Cells

Antibody–drug conjugates (ADCs), which are currently being developed, may become promising cancer therapeutics. Folate receptor α (FOLR1), a glycosylphosphatidylinositol-anchored membrane protein, is an attractive target of ADCs, as it is largely absent from normal tissues but is overexpressed in ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsunaga, Yuki, Yamaoka, Toshimitsu, Ohba, Motoi, Miura, Sakiko, Masuda, Hiroko, Sangai, Takafumi, Takimoto, Masafumi, Nakamura, Seigo, Tsurutani, Junji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930947/ https://www.ncbi.nlm.nih.gov/pubmed/33535554 http://dx.doi.org/10.3390/antib10010006

Ejemplares similares

Antibody‐drug conjugate MORAb‐202 exhibits long‐lasting antitumor efficacy in TNBC PDx models
por: Furuuchi, Keiji, et al.
Publicado: (2021)

Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb‐202 in gastric cancer
por: Sakai, Hitomi, et al.
Publicado: (2021)

Blockade of EGFR Activation Promotes TNF-Induced Lung Epithelial Cell Apoptosis and Pulmonary Injury
por: Yamaoka, Toshimitsu, et al.
Publicado: (2019)

HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer
por: Yamaoka, Toshimitsu, et al.
Publicado: (2020)

Innovative use of magnetic resonance imaging-guided focused ultrasound surgery for non-invasive breast cancer: a report of two cases
por: Matsutani, Akiko, et al.
Publicado: (2020)

Receptor Tyrosine Kinase-Targeted Cancer Therapy
por: Yamaoka, Toshimitsu, et al.
Publicado: (2018)

Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate
por: Tang, Thao, et al.
Publicado: (2022)

Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms
por: Yamaoka, Toshimitsu, et al.
Publicado: (2017)

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
por: Huang, Ming-ju, et al.
Publicado: (2018)

Up-regulation of Syndecan-4 contributes to TGF-β1-induced epithelial to mesenchymal transition in lung adenocarcinoma A549 cells
por: Toba-Ichihashi, Yoko, et al.
Publicado: (2015)

Tandem CAR-T cells targeting FOLR1 and MSLN enhance the antitumor effects in ovarian cancer
por: Liang, Zhen, et al.
Publicado: (2021)

Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors
por: Necela, Brian M., et al.
Publicado: (2015)

Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer
por: Kim, Minsung, et al.
Publicado: (2018)

BRCAness as a prognostic indicator in patients with early breast cancer
por: Liu, Lei, et al.
Publicado: (2020)

Correction: Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors
por: Necela, Brian M., et al.
Publicado: (2015)

Differentially expressed genes in embryonic cardiac tissues of mice lacking Folr1 gene activity
por: Zhu, Huiping, et al.
Publicado: (2007)

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb‐004) in metastatic soft‐tissue sarcomas
por: Jones, Robin L., et al.
Publicado: (2019)

Reinforcing one-carbon metabolism via folic acid/Folr1 promotes β-cell differentiation
por: Karampelias, Christos, et al.
Publicado: (2021)

High Expression of Folate Receptor Alpha (FOLR1) is Associated With Aggressive Tumor Behavior, Poor Response to Chemoradiotherapy, and Worse Survival in Rectal Cancer
por: Chen, Chih-I, et al.
Publicado: (2022)

CIC de novo loss of function variants contribute to cerebral folate deficiency by downregulating FOLR1 expression
por: Cao, Xuanye, et al.
Publicado: (2021)

FOLR1-induced folate deficiency reduces viral replication via modulating APOBEC3 family expression
por: Wu, Jing, et al.
Publicado: (2023)

Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer
por: Nishihara, Shigetoshi, et al.
Publicado: (2022)

Folic acid modifies the shape of epithelial cells during morphogenesis via a Folr1 and MLCK dependent mechanism
por: Martin, Jessica B., et al.
Publicado: (2019)

Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients
por: Iwase, Toshiaki, et al.
Publicado: (2015)

Diagnostic performance of dedicated breast positron emission tomography
por: Hashimoto, Rikako, et al.
Publicado: (2022)

FolR1: a novel cell surface marker for isolating midbrain dopamine neural progenitors and nascent dopamine neurons
por: Gennet, Nicole, et al.
Publicado: (2016)

First case report of cerebral folate deficiency caused by a novel mutation of FOLR1 gene in a Chinese patient
por: Zhang, Ciliu, et al.
Publicado: (2020)

Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma
por: Xiang, Chan, et al.
Publicado: (2023)

Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR-Activating Mutation
por: Nishihara, Shigetoshi, et al.
Publicado: (2022)

CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target
por: Le, Quy, et al.
Publicado: (2022)

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers
por: Notaro, Sara, et al.
Publicado: (2016)

Memorandum 202: plans for 1985
por: Garreta, D, et al.
Publicado: (1984)

Abstract - SUA202 (Pediatric)
Publicado: (2020)

Abstract - SUA202 (Transplant)
Publicado: (2020)

Abstract - SUA202 (Endourology)
Publicado: (2020)

Abstract - SUA202 (Reconstructive)
Publicado: (2020)

Abstract - SUA202 (Oncology)
Publicado: (2020)

Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors
por: Stewart, David J, et al.
Publicado: (2014)

Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT
por: Jia, Li, et al.
Publicado: (2021)

Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
por: Masuda, Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_22kv9dmk2ml9bd1u5r11bcujog